1. An overview of hematopoietic stem cell transplantation related thrombotic complications. (November 2016) Authors: Sahin, Ugur; Ataca Atilla, Pinar; Atilla, Erden; Toprak, Selami Kocak; Demirer, Taner Journal: Critical reviews in oncology/hematology Issue: Volume 107(2016) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An overview of hematopoietic stem cell transplantation related thrombotic complications. (November 2016) Authors: Sahin, Ugur; Ataca Atilla, Pinar; Atilla, Erden; Toprak, Selami Kocak; Demirer, Taner Journal: Critical reviews in oncology/hematology Issue: Volume 107(2016) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. How to manage poor mobilizers for high dose chemotherapy and autologous stem cell transplantation?. Issue 2 (April 2017) Authors: Ataca Atilla, Pinar; Bakanay Ozturk, Sule Mine; Demirer, Taner Journal: Transfusion and apheresis science Issue: Volume 56:Issue 2(2017) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗